Gene therapy is making a comeback in the world of neurodegeneration research, as evidenced by this year’s Society for Neuroscience conference held in Chicago. With the success of Novartis Zolgensma (gene therapy for spinal muscular atrophy in infants), money...
Imagine having a stroke or Parkinson’s disease and how difficult it could be to get to a doctor’s appointment. Or being in a remote part of the world where medical facilities are few and far between. Having a video clip of your movements being reviewed and diagnosed...
Parkinson’s disease spells big trouble for the U.S. and its growing population of aging baby boomers. The ailment may affect over 1 million Americans with 50,000 to 60,000 new diagnosed cases per year. An investigator at the Center for Neurosciences at the Feinstein...
The Center for Neurodegenerative Disease Research (CNDR) at the University of Pennsylvania received $18.1 million to study the underlying genetic mechanisms that caused Alzheimer’s Disease, Dementia, and Parkinson’s Disease to progress as well as how those mechanisms...
Some 85% of people over 60 use prescription drugs, according to the National Center for Health Statistics (NCHS). Yet, older people are not well represented in clinical trials, the gold standard for testing the safety and efficacy of medications, the NCHS says. The...
Northwestern Medicine researchers, led by Dr. Dimitri Krainc, used patient-derived neurons to develop and test a novel strategy to treat Parkinson’s disease by mitigating the effects of harmful mutations. Taking a different approach, the Chicago-based group sought to...
